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Abstract
Meningoencephalomyelitis of unknown origin (MUO) is a common, naturally-occurring, clini-
cal disease of pet dogs. It is an immune-mediated condition that has many similarities with
experimental autoimmune encephalitis (EAE) in rodents and so investigation of its patho-
genesis may aid in understanding factors that contribute to development of multiple sclero-
sis in people. Gut microbiota are known to modulate immune responses that influence
susceptibility to immune-mediated brain disease. In this study we aimed to compare abun-
dance of specific constituents of the fecal microbiota, namely Faecalibacterium prausnitzii
and Prevotellaceae, between dogs diagnosed with MUO and matched controls. Fecal sam-
ples were obtained from 20 dogs diagnosed with MUO and 20 control dogs matched for
breed, age and gender. Bacterial abundance was measured using qPCR and 16S rRNA
sequencing. We found that Prevotellaceae were significantly less abundant in cases com-
pared with controls (p = 0.003) but there was no difference in abundance of F.prausnitzii.
There was no evidence of other differences in gut microbiota between groups. These data,
derived from this naturally-occurring canine clinical model, provide strong corroborative evi-
dence that high abundance of Prevotellaceae in the gut is associated with reduced risk for
developing immune-mediated brain disease.
Introduction
Disease in pet dogs treated by veterinarians forms a unique, frequently-overlooked, resource
of biomedical translational data [1]. There are many advantages of these diseases as models of
their human equivalents. First, they arise spontaneously, often through multifactorial etiolo-
gies similar to those that induce the parallel diseases in humans. Second, both pet dogs and
humans share a common environment that may be a source of disease-causing risks. Third,
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diagnostic procedures and therapeutic interventions are broadly similar between humans and
dogs with similar diseases. Within the field of neurology these features of similarity have been
most extensively discussed in regard to spinal cord injury [2,3]. In this study we investigate
possible etiologies for another canine disease: meningoencephalomyelitis of unknown origin
(MUO), which models many aspects of multiple sclerosis in people.
MUO is an umbrella term used to summarize clinically-diagnosed immune-mediated
inflammatory disease of the meninges, spinal cord and, especially, the brain of dogs [4]. On
histopathologic examination a variety of sub-types of MUO are recognized, differentiated
mainly by the predominance of white or grey matter involvement, the extent of necrosis and
whether meninges are also inflamed [5,6], but all sub-types show the common feature of
inflammatory cell infiltrate. In common with multiple sclerosis (MS) [7], much effort has been
directed toward searching for infectious causes for MUO in dogs [8], and has proved similarly
unsuccessful.
Traditionally, experimental autoimmune encephalomyelitis (EAE) in rodents has been
widely used as a model for investigating the pathogenesis of multiple sclerosis [9]. The self-
directed immune response in EAE can be initiated by injection of central nervous system
(CNS)-derived antigens into susceptible animals or by passive transfer of antibodies from
affected animals [10,11]. Recent work has suggested that the self-directed immune response,
which is dependent upon a suitable systemic immune environment, can in turn be modulated
by components of the gut microbiome [12]. Thus, germ-free mice are resistant to development
of EAE, whereas those with wild-type gut microbiota remain susceptible [12,13]. Further sup-
port for this pathogenetic mechanism is provided by the changes in susceptibility to EAE that
can be elicited by using antibiotics [14], oral immunization with vaccine strain of Salmonella
[15], or probiotic mixtures [16].
Subsequent comparisons of the gut microbiome between MS patients and unaffected indi-
viduals have provided evidence that it may also play a role in the etiopathogenesis of MS
[17,18]. Notably, an association has been made between development of MS and depleted pop-
ulations of Faecalibacterium prausnitzii, Prevotella spp, or both [18], which also supports a
more widely held belief that these two bacterial types may be protective against development
of self-directed immune responses [19–21].
MUO in dogs shows many histological and immunological similarities to both EAE in
rodents and MS in humans [22,23], suggesting a common etiology and implying its value in
interpretation of the potential importance of the gut microbiome in development of immune-
mediated encephalomyelitis in humans. Of further benefit is the low level of genetic diversity
within defined dog breeds [24], implying that genetic influences on susceptibility to this dis-
ease [25–28] can be controlled by experimental design. In this study, we exploited the well-
known breed, age and gender susceptibility [29] to design a case-control study in which to dis-
sect the effects of gut microbial populations and other possible environmental triggers on
development of MUO in dogs. We hypothesized that, in fecal samples obtained from dogs
with MUO, there would be a decreased abundance of F.prausnitzii and, or, Prevotellacea, com-
pared with that found in unaffected dogs.
Methods
Materials and methods
Fecal samples were collected from dogs (‘Cases’) diagnosed with MUO at the veterinary hospi-
tals of Iowa State University (ISU) and Texas A&M University (TAMU) and stored in a -80˚C
freezer for analysis at completion of case recruitment. We also collected fecal samples from
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matched control dogs (‘Controls’) that were presented for diagnosis and treatment through the
same veterinary school hospitals for other conditions.
Cases. Typical cases of MUO present with signs of brain dysfunction such as seizures or
brainstem dysfunction (often disorders of vestibular function), although signs of disease any-
where in the CNS can be caused by MUO. Diagnostic tests include magnetic resonance imag-
ing (MRI) scans and cerebrospinal fluid (CSF) analysis. Important rule-outs include infectious
causes of brain inflammation such as Toxoplasma, canine distemper virus infection, Neospora
and, depending on geographical location, tick-borne diseases. Final confirmation of the diag-
nosis is achieved through post mortem examination but cases can usually be securely diag-
nosed through clinical tests and long-term response to therapy alone.
Potential Cases presented with various neurological signs relating to dysfunction of the
brain (we specifically excluded dogs that were suspected of having MUO but had signs affect-
ing the spinal cord or optic nerves alone), underwent routine MRI scanning and CSF analysis.
For inclusion as a Case a dog had to show typical areas of diffuse hyperintensity on
T2-weighted MRI scans (Fig 1) and increased cell counts (>5 white cells per μL) on CSF analy-
sis. We also included any dogs that were definitively diagnosed at post mortem whether they
fulfilled other clinical criteria or not. Dogs with evidence of gastrointestinal disease were spe-
cifically excluded, as were those that tested positive for any infectious disease. Any dog that
had received oral antibiotics within 4 weeks of diagnosis, or that was diagnosed with cancer or
immune-mediated disease affecting any part of the body, was also excluded.
Fig 1. 3T T2W axial MR image at the level of the caudal colliculus illustrating the typical
hyperintensity (*) that is often prominent adjacent to the ventricles in cases of MUO. This dog also
exhibits ventricular asymmetry (‘V’ indicates left ventricle), which is a common incidental finding in small breed
dogs (this was a pug).
doi:10.1371/journal.pone.0170589.g001
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After MRI and CSF had been obtained owners were asked for permission to take a fecal
sample and for their assistance in completing the study record form to complete a short ques-
tionnaire (see below). This protocol was specifically reviewed and approved by the Iowa State
University Institutional Animal Care and Use Committee (log number 4-12-7347-K).
Controls. These were dogs that presented to ISU or TAMU for investigation or treatment
of other conditions but were of the same breed, gender and matched age. In line with recom-
mendations for case-control studies [30], we specifically sought Control animals from those
presented to our veterinary university clinics because they were derived from the same popula-
tion as the Cases. Control dogs were subject to the same exclusions as Cases, therefore dogs
diagnosed with any gastro-intestinal disease, proven or suspected immune-mediated disease,
cancer, or that had received systemic antibiotic therapy within 4 weeks were excluded. Owners
of dogs that fulfilled these requirements (identified through daily appointment records) or that
were of an age and breed likely to match in future with a Case were approached to seek consent
to obtain a fecal sample and complete the Study Record Form, whether or not a matched Case
had previously been recruited.
Fecal samples. Feces (at least 30g) were obtained from the rectum using a gloved finger
and then stored in sterile containers in a -80˚C freezer until the end of the sample acquisition
phase.
Study Record Form. A specifically-designed Study Record Form recorded demographic
data plus whether the dog was a Case or Control and the date of the most recent antecedent
vaccination (of any type). Vaccination of both Cases and Controls within the previous calendar
month was recorded as a dichotomous variable. The home environment in which the dog
lived was categorized as rural, semi-rural (small town) or urban. We also asked questions
about diet in general terms, such as whether dry (kibble), wet (canned) or home-cooked food
was provided but did not request details. Any further follow-up information (e.g. post-mortem
report) was added as free text.
Gut microbiota analysis. DNA isolation: DNA was extracted from the swabs with a
MoBio Power soil DNA isolation kit (MoBio Laboratories, USA) following the manufacturer’s
instructions.
Sequencing of 16S rRNA genes: The V4 region of the 16S rRNA gene was amplified with
primers 515F (5’-GTGCCAGCMGCCGCGGTAA-3’) and 806R (5’-GGACTACVSGGGTATC
TAAT-3’) at the MR DNA Laboratory (Shallowater, TX, USA) as previously described [31].
The Nextera1 DNA sample Preparation kit including sequencing adapters and sample specific
barcodes was used to prepare a DNA library and sequenced at MR DNA on an Illumina
MiSeq instrument.
The raw sequence data was screened, trimmed, filtered, denoised and barcodes and chimera
sequences were depleted from the dataset using QIIME v1.8 pipeline and UCHIME. Opera-
tional Taxonomic Units (OTUs) were assigned based on at least 97% sequence similarity
against the Greengenes reference database. Sequences were rarefied to an even depth of 6,900
sequences per sample to account for unequal sequencing depth across samples. Observed spe-
cies richness, Chao 1, and Shannon indexes were determined using QIIME. The sequences
were deposited in SRA under accession number PRJNA319388.
Statistical analysis. Our study was designed to be analyzed using conditional logistic
regression so as to take advantage of the case-control design, in which each Case was matched
with a single Control of the same breed, gender and approximate age. MUO status (yes or no)
was the dependent outcome variable. The primary, pre-defined outcome measure—based on
the previous data on association in multiple sclerosis [18]—was to test whether reduced abun-
dance of F.prausnitzii and Prevotellaceae was significantly associated with diagnosis of MUO.
We also examined the association with two other putative risk factors for MUO that might
Gut Microbiota in Canine Encephalitis
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also have relevance for development of MS in people: vaccination status (vaccinated within the
previous month or not) and environment (in three graded categories). Analysis was conducted
using Stata 11.0 (Stata Corp, College Station, TX) with P<0.05 taken to indicate significance.
We also planned further exploratory comparison of the microbial populations between
Cases and Controls using analysis of beta-diversity by unweighted Unifrac distance metrics,
similarly to a previously published report [31]. Statistical significance of the resulting distance
metric was tested by analysis of similarities (ANOSIM) using the QIIME software.
There was no formal power calculation for this study, because we had little previous avail-
able information on which to base a sample size calculation, although the study by Miyake et al
(2014) [18] examined 20 human MS patients. Instead, we aimed to accumulate as many
matched pairs as possible during the 2-year period of study sponsorship (American Kennel
Club Health Foundation, grant # 01731).
Results
Samples with adequate documentation of all variables were collected from a total of 70 dogs, of
which 39 were Cases and 31 were Controls. As expected from previous studies [29], the major-
ity were small breed dogs (<20kg bodyweight). There were 20 matched pairs of dogs (40 dogs
in total); 5 pairs were male and 15 pairs were female; this gender predominance is also similar
to that reported in previous studies [29].
The full breed list is: Chihuahua (n = 8), Maltese (n = 6), Labrador (n = 4), pug (n = 4),
shih-tzu (n = 4), then golden retriever, Chesapeake bay retriever, Weimeraner, dachshund,
beagle, miniature pinscher and bichon frise (each n = 2). Cases were presented at the following
periods in the year: 8 dogs in winter (Dec-Feb); 6 dogs in spring (Mar-May); 3 dogs in summer
(Jun-Aug) and 3 dogs in fall (Sep-Nov).
Pre-specified comparisons between Cases and Controls
Univariable analysis. Initially we examined the abundance of F.prausnitzii and Prevotella-
ceae in Cases and their matched Controls, neither of which constituted normally-distributed
data. Amongst all sampled dogs F. prausnitzii abundance ranged from 0–0.9% of the total bac-
terial population and differed little between Cases and Controls (Wilcoxon paired signed ranks
test, P = 0.198). In 9 of 21 Cases and 5 of 21 Controls no bacteria of this species were detected at
all. Abundance of Prevotellaceae ranged from 0.01–23.91% across all sampled dogs but was sig-
nificantly different between Cases and Controls (Wilcoxon paired signed ranks test, P = 0.003)
(Fig 2). The data we recorded on diet proved to be insufficiently detailed to allow further anal-
ysis. Owners in both groups reported feeding similar diets in general terms: 17/21 Cases and
19/21 Controls were fed various brands of kibble food as their main, or only, diet. However,
most owners also indicated that there was variation in the daily diet and many dogs received
variable amounts of table scraps and rewards.
Conditional logistic regression (which takes advantage of pair-matching) was used to exam-
ine the relationships between Prevotellaceae and F.prausnitzii abundances and development of
MUO in more detail. Because the data populations were not normally-distributed and because
we could not assume that relationships between bacterial abundance and development of
MUO were linear we divided the populations into tertiles (i.e. low, medium and high abun-
dance) using an automatic function in Stata. This analysis revealed a tendency toward lower
prevalence of MUO in animals with higher abundance of F.prausnitzii, although this was not
statistically significant in this population (Odds ratio [OR] = 0.575; P = 0.192). In contrast
there was a stronger, statistically-significant relationship of reduced likelihood of MUO in
dogs with higher abundance of Prevotellaceae (OR = 0.303; P = 0.038) (Table 1). This was also
Gut Microbiota in Canine Encephalitis
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Fig 2. Dot plots illustrating relative abundance of F.prausnitzii (A) and Prevotellaceae (x103) (B) in
Cases and matched Controls. Prevotellaceae abundance is shown on a log scale to improve detail; this is
not possible for F.prausnitzii because many animals had a zero score.
doi:10.1371/journal.pone.0170589.g002
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reflected in the significant trend of decreasing odds of developing MUO with increasing abun-
dance of Prevotellaceae (χ2 = 6.89; P = 0.010) (Table 2).
We next examined the possible effects of two other possible environmental factors: recent
vaccination and home environment. None of the unaffected Control dogs had been vaccinated
within the past month, whereas 5/20 Cases had been, resulting in a statistically significant asso-
ciation (Fisher’s exact test, p = 0.047). Living environment appeared to be weakly associated
with development of MUO; overall the odds of developing MUO were lower for dogs living in
a rural environment that for those living in urban areas although not significant at the P<0.05
level (OR = 2.810; P = 0.067; Table 1) and this was also reflected in the significant trend of
odds associated with increasingly more populated environments (χ2 = 4.53; P = 0.033;
Table 3).
Multivariable analysis. We intended to include all the relevant variables in multivariable
conditional logistic regression but, because of the lack of recent vaccination in any Control
dogs, it was not possible to include this variable. When all three other variables were included
together in multivariable conditional regression analysis there was considerable change in the
association of diagnosis of MUO with the dog’s living environment (OR = 10.936), and moder-
ate changes for association with F.prausnitzii (OR = 0.255) and with Prevotellaceae
(OR = 0.446) (Table 4). A series of subsequent exploratory analyses using stratification of
exposure to both Prevotellaceae and environmental categories, plus χ2 analysis of association
between these variables, were impaired by null values in some categories. Nevertheless, inspec-
tion of the odds ratios (and the instability of the figures for environment) strongly suggests
interaction amongst these variables.
Table 1. Results of univariable conditional logistic regression analyzing association of various putative risk factors (expressed as categories)
with the development of MUO.
Odds ratio SE Z P 95% CI
F.prausnitizii 0.574 0.244 -1.30 0.192 0.250–1.322
Prevotellaceae 0.303 0.175 -2.07 0.038 0.098–0.937
Environment 2.809 1.584 1.83 0.067 0.930–8.481
doi:10.1371/journal.pone.0170589.t001
Table 2. Analysis of odds of development of MUO associated with various abundances of Prevotellaceae.
Prevotellaceae abundance Cases Controls Odds 95% CI
Low 7 1 7.000 0.861–56.895
Medium 9 9 1.000 0.397–2.519
High 4 10 0.400 0.125–1.275
Test of trend of odds: χ2 = 6.65; P = 0.010
doi:10.1371/journal.pone.0170589.t002
Table 3. Analysis of odds of development of MUO associated with various environmental conditions.
Environment Cases Controls Odds 95% CI
Rural 1 6 0.167 0.020–1.384
Small town / edge of city 8 8 1.000 0.375–2.664
Urban 11 6 1.833 0.678–4.957
Test of trend of odds: χ2 = 4.53; P = 0.033
doi:10.1371/journal.pone.0170589.t003
Gut Microbiota in Canine Encephalitis
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Exploratory analysis of bacterial phyla populations. One of the difficulties in analyzing
gut microbiota is that there is an almost infinite number of possible hypotheses to test. Never-
theless, our next step was preliminary exploratory analysis of the bacterial phyla abundances
that were available from the sequencing studies. Similar studies have been conducted for
human patients with MS [17,18] and we used a parallel methodology.
Abundance of bacteria was recorded for each of 8 major phyla (Euryarchaeota, Actinobac-
teria, Bacteroidetes, Deferribacteres, Firmicutes, Fusobacteria, Proteobacteria, Tenericutes).
Abundance was recorded as zero in a substantial proportion (>50%) of all dogs in some cate-
gories (Euryarchaeota, Deferribacteres, Tenericutes) leaving a total of 5 phyla for analysis of the
relationship between abundance and diagnosis of MUO. For none of these phyla was there evi-
dence of a statistical difference in abundance between Cases and Controls (Fig 3) and condi-
tional logistic regression analysis of the matched-pair data using tertiles (as described above
for Prevotellaceae and F.prausnitzii) did not support an association between abundance of any
of these bacterial phyla and development of MUO (Table 5).
Finally, we used principal component analysis as a means to detect more global association
between fecal microbial content and development of MUO. Alpha diversity as described by
Chao 1, Observed species (species richness), and Shannon diversity index were not signifi-
cantly different between paired samples. PCoA plots of unweighted Unifrac distances (Fig 4)
Table 4. Multivariable conditional logistic regression analyzing association of various putative risk factors with development of MUO.
Odds ratio SE Z P 95% CI
F.prausnitizii 0.255 0.227 -1.54 0.125 0.044–1.460
Prevotellaceae 0.446 0.291 -1.24 0.216 0.124–1.603
Environment 10.936 16.051 1.63 0.103 0.616–194.142
doi:10.1371/journal.pone.0170589.t004
Fig 3. Tukey box-and-whisker plots illustrating relative abundance of the major bacterial phyla in
fecal samples from Case and Control dogs.
doi:10.1371/journal.pone.0170589.g003
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confirmed that there was not significant clustering between samples from Case or Control
groups (R-statistic = 0.054; ANOSIM p = 0.15).
Discussion
The analysis presented here supports an association between low Prevotellaceae abundance
and a diagnosis of MUO in dogs, which also corroborates previous observations of an associa-
tion between this bacterial group and diagnosis of MS in people [18]. Such corroboration,
especially in a different species, is important because investigation of such a complicated sys-
tem as the gut microbiome carries an inherently high risk of false discovery. In this study, we
specifically targeted only two bacterial populations in our primary pre-specified analysis
implying that the risk of false discovery is low. Therefore, this evidence carries high value as
corroboration of the importance of Prevotellaceae in reducing risk of immune-mediated CNS
disease. Interestingly, low abundance of Prevotellaceae has also been associated with Parkin-
son’s disease in people [32]. The rigid case-control design has enabled us to minimize the pos-
sible confounding factors of age, gender and genetic variability.
On the other hand, the possible association of low abundance of F.prausntizii with MS in
people [17,18] has not been supported by our data. This could simply be because of the rela-
tively low power of our study, especially since many of the dogs had zero counts of this bacte-
rium that may have confounded our ability to make associations. Nevertheless, our
observations on matched pairs of dogs (Fig 1) would suggest that any effects must be relatively
small since in many pairs the Case had a higher abundance of F.prausnitzii than its matched
Control. It is also possible that for some reason, such as diet, dogs in general, or dogs in this
specific study, simply have low levels of F.prausnitzii and its association with immune-medi-
ated disease in this species is not the same as in others. Lastly, in the study by Canterel at el
(2015) [17] the abundance of various bacterial groups, including Faecalibacterium, was altered
by vitamin D levels. Because dogs are not dependent on sunlight for production of vitamin D
Table 5. Results of exploratory multivariable conditional logistic regression on association of various bacteria phyla with development of MUO.
Odds ratio SE Z P 95% CI
Actinobacteria 1.168 0.514 0.35 0.724 0.493–2.768
Bacterioidetes 0.456 0.230 -1.55 0.120 0.170–1.228
Firmicutes 0.736 0.411 -0.55 0.583 0.247–2.197
Fusobacteria 0.705 0.371 -0.66 0.508 0.251–1.980
Proteobacteria 0.582 0.293 -1.07 0.283 0.217–1.563
doi:10.1371/journal.pone.0170589.t005
Fig 4. 2-dimensional representations of the principal component analysis illustrating the lack of clustering of
microbiota constituents in Cases (blue squares) or Controls (red dots).
doi:10.1371/journal.pone.0170589.g004
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[33], levels of this vitamin are likely adequate in dogs receiving a reputable manufacturer’s diet
(as all dogs in this study were) and so the relationship between levels of this vitamin and abun-
dance of this specific fecal bacterium may differ between the two species.
Two further findings in this study may be useful in research into etiology of MS in humans.
First, we show the possibility that MUO may, in some cases, be triggered by vaccination. How-
ever, it is important that this finding be treated with caution: there were few dogs that had
received vaccination and developed disease and so confidence in this result must be low. Nev-
ertheless, the possibility of vaccine triggering MS or other CNS demyelinating conditions has
been previously studied in MS patients; overall the conclusions have been that there is no evi-
dence of increased risk [34,35], although there is a suggestion that some individuals that are in
sub-clinical stage of other demyelinating diseases may be triggered into disease by vaccination
[35]. Our results are consistent with this explanation.
Pet dogs can also have potential for helping to identify disease risk factors in the environ-
ment because they share living spaces with humans and so may have similar exposure patterns.
In this study, there is evidence that an urban environment is associated with increased risk of
MUO. Our study provides a little support for the notion that this risk is mediated via effects on
the microbiome (because there was weak evidence of interaction between environment and
Prevotellaceae abundance) and so other mechanisms could be evoked. In humans there is
strong evidence that specific regions of the world carry risk for development of MS, in particu-
lar through linkage with vitamin D status [36]. This would be an unlikely association in dogs
because, as noted above, they do not manufacture vitamin D in the skin [33]; instead, dogs
may be able to provide evidence of more local environmental risk, such as the characteristics
of a specific neighborhood that might play a role in susceptibility to immune-mediated CNS
diseases. There is some previous evidence that urban living may be a risk factor for MS in peo-
ple [37], and this has been suggested to be because of increased hygiene. It is possible that the
same could apply to dogs living in urban environments (since they have less exposure to wild-
life, for instance) but, alternatively, urban-living dogs may also have greater exposure to envi-
ronmental toxins, such as organic solvents, which have been suggested as possible risks in
human immune-mediated disease [38]. On the whole, dogs are excellent sentinel species for
environmental toxins because of their well-developed scavenging behavior.
Finally, the association of high abundance of Prevotellaceae with reduced likelihood of
developing MUO may have two general explanations. As a ‘fermenting’ group of bacteria, Pre-
votellaceae produce butyrate, which has been identified as a specific inducer of Treg cell differ-
entiation [39]. It is possible that this butyrate-producing metabolic profile may thus constitute
the uniting mechanism of resistance to immune-mediated disease thought to be mediated by
both Prevotellaceae and F. prausnitzii [21]. Similarly, hormones produced by specific gut
microbes could also directly influence the immune system [40]. Together these effects may
modulate the changed intestinal permeability that has been detected in both MS patients [41]
and rats with EAE [42]. On the other hand, it is also possible that high Prevotellaceae abun-
dance might result as a bystander effect of another interaction between the host (immune sys-
tem) and the gut microbiome. If this were true, a high population of Prevotellaceae might
simply be a biomarker of an immune system that is in a state that moderates inflammatory
responses. Support for this notion is provided by their relatively low overall abundance: Prevo-
tellaceae were recorded in our study as a median of only ~0.2% of the detected bacterial micro-
biota; nevertheless, hormonal effects need not depend on high abundance.
What limitations might there be in the conclusions that can be reached from this study?
First, because it was designed with the specific aim of exploring the possibility that reduced
fecal bacterial population of one pre-specified species and one pre-specified family might be
associated with development of this specific immune-mediated disease these results must be
Gut Microbiota in Canine Encephalitis
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regarded as robust. There is little risk of a false positive finding with this experimental design
and, furthermore, the outcome largely corroborates previous evidence. Nevertheless, there are
an almost unlimited number of unrecorded variables, such as specific dietary components,
dog activity levels and gut permeability that might possibly have some influence on the devel-
opment of MUO and might have been overlooked in this study. On the other hand, there is lit-
tle reason to suppose that these factors would be systematically differently distributed between
our Case population and the Controls, especially since we specifically selected our Controls
from animals presenting to our clinics for treatment. Further investigation in new sample pop-
ulations is required to investigate all the possible interactions amongst gut microbiota, envi-
ronment and other disease states.
Finding different abundances of specific bacterial species between affected and unaffected
groups in this study directs a spotlight at diet as a possible cause of these differences. Here we
recorded only coarse information that proved impossible to analyze in a meaningful way since
there was insufficient detail to be able to analyze the proportions of specific nutrients in any
particular animal’s diet. Unfortunately, pet dog diets are often difficult to analyze because
there is a great deal of variability in the way that owners feed dogs, both between individuals
and between days. Further exploration of these dietary effects will require collaboration with a
specialist nutritionist.
There is an almost infinite variety of environmental factors that could be involved in the
risk of developing MUO and it is not possible for all these to be investigated, or accounted for,
in a single study. For instance, there is some evidence that ingestion of non-steroidal anti-
inflammatory drugs (NSAIDs) may alter not only gut permeability, but also may be associated
with changes in gut microbiota [43]. Unfortunately, investigation of such effects is complicated
because different NSAIDs appear to be associated with different gut microbial constituents
and may also be affected by duration of therapy. Therefore, the possible effect of NSAID
therapy, which was accounted for in this study as an unknown that would ‘randomize out’,
provides an example of a factor that requires further investigation in the context of CNS
inflammatory disease. On the other hand, in this study we did collect simple data on a small
number of some possible explanatory variables, with the aim of providing some preliminary
information on possible risk factors for development of MUO in dogs and, by implication,
possibly also for MS in humans. The study design implies that the results of analysis of the
association of these other factors (apart from the targeted bacterial populations) with develop-
ment of MUO must be regarded as tentative and will require further validation in repeated
studies. For instance, the apparent association of recent vaccination with development of
MUO is weak—few dogs had been vaccinated in temporal proximity to disease onset and so
the confidence intervals associated with this possible risk are wide—implying low analytical
power and low confidence in their repeatability. Furthermore, it is plausible that different vac-
cinations might differ in their effects. The association of urban living with development of
MUO is more robust, especially since there is a strong trend of odds across the range of expo-
sure (Table 4) and there is a previous suggestion of a link between urban living and develop-
ment of MS in people [37]. Nevertheless, our environmental data are not highly detailed (for
instance we did not link zip code to population density) and will therefore require verification
in a new sample population.
Supporting Information
S1 Table. Signalment, Prevotellacae and F prausnitzii abundance. https://dx.doi.org/10.
6084/m9.figshare.4541227.v1. doi: 10.6084/m9.figshare.4541227.v1.
(XLSX)
Gut Microbiota in Canine Encephalitis
PLOS ONE | DOI:10.1371/journal.pone.0170589 January 26, 2017 11 / 14
S2 Table. Summary of bacterial phyla data. https://dx.doi.org/10.6084/m9.figshare.4541233.
v1. doi: 10.6084/m9.figshare.4541233.v1.
(XLSX)
Author Contributions
Conceptualization: NDJ JS AJ.
Data curation: NDJ JS.
Formal analysis: NDJ JS.
Funding acquisition: NDJ JS AJ.
Investigation: NDJ AB CJA JML IM JW JS.
Methodology: NDJ AJ JS.
Project administration: NDJ JS.
Resources: NDJ JS.
Supervision: NDJ JS.
Validation: NDJ JS.
Visualization: NDJ JS.
Writing – original draft: NDJ JS AJ.
Writing – review & editing: NDJ AB CJA JML IM JW AJ JS.
References
1. Knapp DW, Waters DJ. Naturally occurring cancer in pet dogs: important models for developing
improved cancer therapy for humans. Mol Med Today 1997; 3: 8–11. PMID: 9021736
2. Jeffery ND, Smith PM, Lakatos A, Ibanez C, Ito D, Franklin RJ. Clinical canine spinal cord injury pro-
vides an opportunity to examine the issues in translating laboratory techniques into practical therapy.
Spinal Cord 2006; 44: 584–93. doi: 10.1038/sj.sc.3101912 PMID: 16520817
3. Levine JM, Levine GJ, Porter BF, Topp K, Noble-Haeusslein LJ. Naturally occurring disk herniation in
dogs: an opportunity for pre-clinical spinal cord injury research. J Neurotrauma 2011; 28: 675–88. doi:
10.1089/neu.2010.1645 PMID: 21438715
4. Coates JR, Jeffery ND. Perspectives on meningoencephalomyelitis of unknown origin. Vet Clin North
Am Small Anim Pract 2014; 44: 1157–85. doi: 10.1016/j.cvsm.2014.07.009 PMID: 25239815
5. Talarico LR, Schatzberg SJ. Idiopathic granulomatous and necrotising inflammatory disorders of the
canine central nervous system: a review and future perspectives. J Small Anim Pract 2011; 51: 138–
149
6. Tipold A, Vandevelde M, Schatzberg SJ. Necrotizing encephalitis In: Greene C.E. (ed.), Infectious dis-
eases of the dog and cat. 4th ed. St Louis, Mo: Elsevier, 2012, pp. 856–858
7. Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part I: the role of infection.
Ann Neurol 2007; 61: 288–99. doi: 10.1002/ana.21117 PMID: 17444504
8. Barber RM, Porter BF, Li Q, May M, Claiborne MK, Allison AB et al. Broadly reactive polymerase chain
reaction for pathogen detection in canine granulomatous meningoencephalomyelitis and necrotizing
meningoencephalitis. J Vet Intern Med 2012; 26: 962–8. doi: 10.1111/j.1939-1676.2012.00954.x
PMID: 22686439
9. Constantinescu CS, Farooqi N, O’Brien K, Gran B. Experimental autoimmune encephalomyelitis (EAE)
as a model for multiple sclerosis (MS). Br J Pharmacol 2011; 164: 1079–106. doi: 10.1111/j.1476-
5381.2011.01302.x PMID: 21371012
10. Stromnes IM, Goverman JM. Active induction of experimental allergic encephalomyelitis. Nat Protoc
2006; 1: 1810–1819. doi: 10.1038/nprot.2006.285 PMID: 17487163
Gut Microbiota in Canine Encephalitis
PLOS ONE | DOI:10.1371/journal.pone.0170589 January 26, 2017 12 / 14
11. Robinson AP, Harp CT, Noronha A, Miller SD. The experimental autoimmune encephalomyelitis (EAE)
model of MS: utility for understanding disease pathophysiology and treatment. Handb Clin Neurol 2014;
122: 173–89. doi: 10.1016/B978-0-444-52001-2.00008-X PMID: 24507518
12. Lee YK, Menezes JS, Umesaki Y, Mazmanian SK. Proinflammatory T-cell responses to gut microbiota
promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 2011; 108 Suppl 1:
4615–22.
13. Berer K, Mues M, Koutrolos M, Rasbi ZA, Boziki M, Johner C, et al. Commensal microbiota and myelin
autoantigen cooperate to trigger autoimmune demyelination. Nature 2011; 479: 538–41. doi: 10.1038/
nature10554 PMID: 22031325
14. Ochoa-Repa´raz J, Mielcarz DW, Haque-Begum S, Kasper LH. Induction of a regulatory B cell popula-
tion in experimental allergic encephalomyelitis by alteration of the gut commensal microflora. Gut
Microbes 2010; 1: 103–108. doi: 10.4161/gmic.1.2.11515 PMID: 21326918
15. Jun S, Gilmore W, Callis, Rynda A, Haddad A, Pascual DW. A live diarrheal vaccine imprints a Th2 cell
bias and acts as an anti-inflammatory vaccine. J. Immunol 2005; 175: 6733–6740. PMID: 16272329
16. Kwon HK, Kim GC, Kim Y, Hwang W, Jash A, Sahoo A, et al. Amelioration of experimental autoimmune
encephalomyelitis by probiotic mixture is mediated by a shift in T helper cell immune response. Clin
Immunol 2013; 146: 217–227 doi: 10.1016/j.clim.2013.01.001 PMID: 23416238
17. Cantarel BL, Waubant E, Chehoud C, Kuczynski J, DeSantis TZ, Warrington J, et al. Gut microbiota in
multiple sclerosis: possible influence of immunomodulators. J Investig Med 2015; 63: 729–34. doi: 10.
1097/JIM.0000000000000192 PMID: 25775034
18. Miyake S, Kim S, Suda W, Oshima K, Nakamura M, Matsuoka T, et al. Dysbiosis in the gut microbiota
of patients with multiple sclerosis, with a striking depletion of species belonging to Clostridia XIVa and
IV clusters. PLoS One 2015; 10: e0137429. doi: 10.1371/journal.pone.0137429 PMID: 26367776
19. Brown CT, Davis-Richardson AG, Giongo A, Gano KA, Crabb DB, Mukherjee N, et al. Gut microbiome
metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 dia-
betes. PLoS One 2011; 6: e25792. doi: 10.1371/journal.pone.0025792 PMID: 22043294
20. Hansen AK, Hansen CH, Krych L, Nielsen DS. Impact of the gut microbiota on rodent models of human
disease. World J Gastroenterol 2014; 20: 17727–36. PMID: 25548471
21. Velasquez-Manoff M. Gut Microbiome: The Peacekeepers. Nature 2015; 518: S3–S11 doi: 10.1038/
518S3a PMID: 25715278
22. Park ES, Uchida K, Nakayama H. Comprehensive immunohistochemical studies on canine necrotizing
meningoencephalitis (NME), necrotizing leukoencephalitis (NLE) and granulomatous meningoence-
phalomyelitis (GME). Vet Pathol 2012; 49: 682–92. doi: 10.1177/0300985811429311 PMID: 22262353
23. Lassmann H, Bradl M. Multiple sclerosis: experimental models and reality. Acta Neuropathol 2016; Oct
20. [Epub].
24. Mellanby RJ, Ogden R, Clements DN, French AT, Gow AG, Powell R, et al. Population structure and
genetic heterogeneity in popular dog breeds in the UK. Vet J 2013; 196: 92–7. doi: 10.1016/j.tvjl.2012.
08.009 PMID: 23084740
25. Greer KA, Schatzberg SJ, Porter BF, Jones KA, Famula TR, Murphy KE. Heritability and transmission
analysis of necrotizing meningoencephalitis in the Pug. Res Vet Sci 2009; 86: 438–42. doi: 10.1016/j.
rvsc.2008.10.002 PMID: 19014875
26. Barber RM, Schatzberg SJ, Corneveaux JJ, Allen AN, Porter BF, Pruzin JJ, et al. Identification of risk
loci for necrotizing meningoencephalitis in Pug dogs. J Hered 2011; 102 Suppl 1: S40–6.
27. Safra N, Pedersen NC, Wolf Z, Johnson EG, Liu HW, Hughes AM, et al. Expanded dog leukocyte anti-
gen (DLA) single nucleotide polymorphism (SNP) genotyping reveals spurious class II associations. Vet
J 2011; 189: 220–6. doi: 10.1016/j.tvjl.2011.06.023 PMID: 21741283
28. Schrauwen I, Barber RM, Schatzberg SJ, Siniard AL, Corneveaux JJ, Porter BF, et al. Identification of
novel genetic risk loci in Maltese dogs with necrotizing meningoencephalitis and evidence of a shared
genetic risk across toy dog breeds. PLoS One 2014; 9: e112755. doi: 10.1371/journal.pone.0112755
PMID: 25393235
29. Granger N, Smith PM, Jeffery ND. Clinical findings and treatment of non-infectious meningoencephalo-
myelitis in dogs: a systematic review of 457 published cases from 1962 to 2008. Vet J 2010; 184: 290–
7. doi: 10.1016/j.tvjl.2009.03.031 PMID: 19410487
30. Grimes DA, Schulz KF. Compared to what? Finding controls for case-control studies. Lancet. 2005;
365: 1429–33. doi: 10.1016/S0140-6736(05)66379-9 PMID: 15836892
31. Bell ET, Suchodolski JS, Isaiah A, Fleeman LM, Cook AK, Steiner JM, et al. Faecal microbiota of cats
with insulin-treated diabetes mellitus. PLoS One 2014; 9: e108729. doi: 10.1371/journal.pone.0108729
PMID: 25279695
Gut Microbiota in Canine Encephalitis
PLOS ONE | DOI:10.1371/journal.pone.0170589 January 26, 2017 13 / 14
32. Scheperjans F, Aho V, Pereira PA, Koskinen K, Paulin L, Pekkonen E, et al. Gut microbiota are related
to Parkinson’s disease and clinical phenotype. Mov Disord 2015; 30: 350–8. doi: 10.1002/mds.26069
PMID: 25476529
33. How KL, Hazewinkel HA, Mol JA. Dietary vitamin D dependence of cat and dog due to inadequate cuta-
neous synthesis of vitamin D. General and Comparative Endocrinology 1994; 96: 12–18 doi: 10.1006/
gcen.1994.1154 PMID: 7843559
34. Confavreux C, Suissa S, Saddier P, Bourdès V, Vukusic S; Vaccines in Multiple Sclerosis Study Group.
Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group. N
Engl J Med 2001; 344: 319–26. doi: 10.1056/NEJM200102013440501 PMID: 11172162
35. Langer-Gould A, Qian L, Tartof SY, Brara SM, Jacobsen SJ, Beaber BE, et al. Vaccines and the risk of
multiple sclerosis and other central nervous system demyelinating diseases. JAMA Neurol 2014; 71:
1506–13. doi: 10.1001/jamaneurol.2014.2633 PMID: 25329096
36. Ascherio A, Munger KL, Simon KC. Vitamin D and multiple sclerosis. Lancet Neurol 2010; 9: 599–612
doi: 10.1016/S1474-4422(10)70086-7 PMID: 20494325
37. Malli C, Pandit L, D’Cunha A, Mustafa S. Environmental factors related to multiple sclerosis in Indian
population. PLoS One 2015; 10: e0124064. doi: 10.1371/journal.pone.0124064 PMID: 25902359
38. Barraga´n-Martı´nez C, Speck-Herna´ndez CA, Montoya-Ortiz G, Mantilla RD, Anaya JM, Rojas-Villar-
raga A. Organic solvents as risk factor for autoimmune diseases: a systematic review and meta-analy-
sis. PLoS One 2012; 7: e51506. doi: 10.1371/journal.pone.0051506 PMID: 23284705
39. Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D, et al. Commensal microbe-derived
butyrate induces the differentiation of colonic regulatory T cells. Nature 2013; 504: 446–50. doi: 10.
1038/nature12721 PMID: 24226770
40. Galland L. The gut microbiome and the brain. J Med Food 2014; 17: 1261–72. doi: 10.1089/jmf.2014.
7000 PMID: 25402818
41. Buscarinu MC, Cerasoli B, Annibali V, Policano C, Lionetto L, Capi M, et al. Altered intestinal permeabil-
ity in patients with relapsing-remitting multiple sclerosis: A pilot study. Mult Scler 2016; pii:
1352458516652498.
42. Nouri M, Bredberg A, Westro¨m B, Lavasani S. Intestinal barrier dysfunction develops at the onset of
experimental autoimmune encephalomyelitis, and can be induced by adoptive transfer of auto-reactive
T cells. PLoS One 2014; 9: e106335. doi: 10.1371/journal.pone.0106335 PMID: 25184418
43. Rogers MA, Aronoff DM. The influence of non-steroidal anti-inflammatory drugs on the gut microbiome.
Clin Microbiol Infect 2016; 22: 178.e1–9.
Gut Microbiota in Canine Encephalitis
PLOS ONE | DOI:10.1371/journal.pone.0170589 January 26, 2017 14 / 14
